Number Date Recipients Donors Number of mice Irradiation Source and amount of cells Mean lifespan extension (Δ) 1 1991 [11 ] Mutants gus /gus , young ♀ C57Bl/6, ♀ 18 (e) 91 (c) 2–4 Gy 7 106 , BM (total fraction) Δ = 197% (P = 0.005) 2 1991 [11 ] C57Bl/6, young ♀ C57Bl/6, ♀ 14 (e) 7 (c) 2–4 Gy 6 106 , BM (total fraction) Δ = −26% (P = 0.2) 3 2005 [12 ] C57Bl/6, old ♀ (16 months) C57Bl/6 EGFP+ , young ♀ 38 (e) 17 (c) No irradiation 4 106 , BM (total fraction) injections every 2 months Δ = 6% (P = 0.4) 4 2010 [13 ] BALB, old ♀ (15 months) BALB, fetal tissue, ♂ 10 (e) 10 (c) No irradiation 10 106 , fetal tissue, mesenchymal stem cells, 3 injections Δ = 10% (P = 0.1) 5 2011 [14 ] BALB, old ♀ (18–24 months) C57Bl/6 EGFP+ , young ♂ 14 (e) 10 (c) 5 Gy 106 , mesenchymal stem cells Δ = 16% (P = 0.05) 6 2011 [14 ] BALB, old ♀ (18–24 months) C57Bl/6 EGFP+ , old ♂ (20–24 months) 10 (e) 10 (c) 5 Gy 106 , mesenchymal stem cells Δ = 3% (P = 0.6) 7 2012 [15 ] C57Bl/6, old ♀ (21.5 months) C57Bl/6, young ♂ 8 (e) 9 (c) No irradiation 25 106 , BM (total fraction) 6 injections Δ = 6% (P = 0.4) 8 2013 [16 ] mutants Wrn−/− Tre−/− , young ♂ (3 months) C57Bl/6 EGFP+ , young ♀ 13 (e) 8 (c) 10 Gy 5 106 , BM (total fraction) Δ = 29% (P = 0.01) 9 2014 our work [17 ] C57Bl/6 EGFP, old ♀ (8 months) C57Bl/6 EGFP+ , young ♀ 11 (e) 12 (c) No irradiation 2 106 , BM (total fraction) injection every 3 months Δ = 34% (P = 0.05) 10 This work C57Bl/6 EGFP, old ♀ (8 months) C57Bl/6 EGFP+ , young ♀ 10 (e) 13 (c) No irradiation 2 106 , BM (total fraction) injection every 3 months Δ = 19% (P = 0.20) 11 This work C57Bl/6 EGFP, old ♀ (8 months) C57Bl/6 EGFP+ , young ♀ 21 (e) 25 (c) No irradiation 2 106 , BM (total fraction) injection every 3 months Δ = 25% (P = 0.05) 12 This work C57Bl/6 EGFP, old ♂ (8 months) C57Bl/6 EGFP+ , young ♀, ♂ 21 (e) 12 (c) No irradiation 2 106 , BM (total fraction) injection every 3 months Δ = 10% (P = 0.40) 13 2014, our work [18 ] BALB, old ♀ (13 months) C57Bl/6 EGFP+ , young ♀, ♂ 14 (e) 14 (c) No irradiation 2 106 , BM (total fraction) injection every 3 months Significant difference is not found